SCHEMBL9622

SCHEMBL9622

CC(N)c1cc2cccc(Cl)c2nc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
NFKB1 P19838 1/20 0.49
PNMT P11086 1/20 0.49
LMNA P02545 4/20 0.47
ALDH1A1 P00352 1/20 0.47
GLA P06280 1/20 0.47
TP53 P04637 1/20 0.41
HTT P42858 1/20 0.41
PIK3CD O00329 5/20 0.40
NR4A2 P43354 3/20 0.38
PDCD1LG2 Q9BQ51 3/20 0.35
CD274 Q9NZQ7 3/20 0.35
PDE10A Q9Y233 1/20 0.34
HPGD P15428 1/20 0.34
ALOX5 P09917 1/20 0.33
SRC P12931 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10187 1.00 CYP1A2 (0.49) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL717941 0.85 DRD4 (0.45) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL3656008 0.85 DRD4 (0.45) CYP1A2CYP3A4CYP2D6NFKB1PNMT
Hydrochloric Acid SCHEMBL863976 0.84 LMNA (0.49) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL22476053 0.84 PNMT (0.39) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL19788572 0.84 PNMT (0.39) CYP1A2CYP3A4CYP2D6NFKB1PNMT
Hydrochloric Acid SCHEMBL863977 0.84 LMNA (0.49) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL4178743 0.83 PIK3CD (0.37) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL4182711 0.83 PIK3CD (0.37) CYP1A2CYP3A4CYP2D6NFKB1PNMT
SCHEMBL10251857 0.81 PIK3CD (0.44) CYP1A2CYP3A4CYP2D6NFKB1PNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499126-A1 FUSED BICYCLIC PYRIDINE AND PYRAZINE DERIVATIVES AS KINASE INHIBITORS UCB Pharma, S.A. (BE) 2012-09-19 EP disclosed
EP-2396315-A1 FUSED PYRIDINE AND PYRAZINE DERIVATIVES AS KINASE INHIBITORS UCB Pharma, S.A. (BE) 2011-12-21 EP disclosed
WO-2011058113-A1 FUSED BICYCLIC PYRIDINE AND PYRAZINE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2011-05-19 WO disclosed
WO-2010092340-A1 FUSED PYRIDINE AND PYRAZINE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA S.A. (BE) 2010-08-19 WO disclosed